Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage

Abstract

Ischemic stroke and ischemia/reperfusion (I/R) injury induced by thrombolytic therapy are conditions with high mortality and serious long-term physical and cognitive disabilities. They have a major impact on global public health. These disorders are associated with multiple insults to the cerebral microcirculation, including reactive oxygen species (ROS) overproduction, leukocyte adhesion and infiltration, brain blood barrier (BBB) disruption, and capillary hypoperfusion, ultimately resulting in tissue edema, hemorrhage, brain injury and delayed neuron damage. Traditional Chinese medicine (TCM) has been used in China, Korea, Japan and other Asian countries for treatment of a wide range of diseases. In China, the usage of compound TCM preparation to treat cerebrovascular diseases dates back to the Han Dynasty. Even thousands of years earlier, the medical formulary recorded many classical prescriptions for treating cerebral I/R-related diseases. This review summarizes current information and underlying mechanisms regarding the ameliorating effects of compound TCM preparation, Chinese materia medica, and active components on I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage.

Graphical abstract

TCM preparation, Chinese materia medica and their active compounds show potential to ameliorate I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage with anti-inflammation, anti-oxidation, anti-apoptosis, anti-excitoxicity and pro-neurogenesis as the major underlying mechanisms.

1. Introduction

Stroke is the second leading cause of mortality in the world, resulting in 6,671,000 deaths (11.9% of all deaths) in 2012¹. Pathogenically, ischemic stroke caused by vessel occlusions accounts for 85% of all conditions. Since the core of brain tissue undergoes necrotic cell death within a few minutes of the onset of cerebral ischemia, early restoration of blood flow by thrombolytic therapy decreases morbidity and mortality in these patients². Paradoxically, reperfusion itself evokes additional injury to ischemic penumbra, a region bordering the infarct core, causing the so-called ischemia-reperfusion (I/R) injury. Such injury exacerbates brain damage, leading to increases in severe morbidity in surviving victims. I/R imposes multiple insults to the cerebral microcirculation, including reactive oxygen species (ROS) outburst, inflammatory mediator overproduction, leukocyte infiltration, microvessel hyperpermeabilty, brain blood barrier (BBB) disruption, capillary hypoperfusion, etc. Many of these factors are thought to play significant roles in the pathogenesis of post-ischemic injury in stroke patients³. Much effort has been made to attenuate the microcirculatory disturbances by ablating a single factor in the pathogenesis, including introduction of recombinant tissue plasminogen activator (rtPA)4, 5, antioxidants⁶, anti-intercellular adhesion molecule-1 (ICAM-1) antibody⁷, calcium-stabilizing agents⁸ and anti-excitotoxic agents⁹. However, clinical trials have failed to show positive effects in patients with ischemic stroke. Other therapeutic approaches, such as anti-inflammatory¹⁰ and anti-apoptotic¹¹ agents, are being evaluated, but no successful clinical trials have thus far been reported. These results suggest that such microcirculatory disturbances are part of a complicated pathological process involving multiple, coordinated events. Once initiated, the process may only be interrupted by a remedy consisting of multiple compositions that target the underlying insults.

For more than two thousand years, traditional Chinese medicine (TCM) has been used in China, Korea, Japan and other Asian countries for the clinical treatment of cerebrovascular diseases including stroke, encephalitis, dizziness, insomnia, amnesia, and dementia. In China, the use of compound TCM preparations to treat cerebrovascular diseases dates back to the Han Dynasty. “Treatise on Cold Damage (Shang Han Lun)” and “Synopsis of the Golden Chamber (Jin Kui Yao Lue)” appeared at that time which recorded several classical formulas, including Chaihu Jia Longgu Muli Tang, Guizhi Fuling Wan, Gualou Guizhi Tang, and others, which were devoted to cope with cerebrovascular diseases. In the Tang dynasty, medical formulas were further developed, as shown by “Important Prescriptions Worth a Thousand Gold for Emergency (Qian Jin Fang)” and “Arcane Essentials from the Imperial Library (Wai Tai Mi Yao)”; these documented the use of Xiaoxuming Tang, Dihuang Yinzi and Huanglian Jiedu Tang for the treatment of cerebrovascular diseases.

In the dynasties that followed, more compound TCM preparations were used in clinic. In the Song dynasty, treatments included Sijunzi Tang and Longdan Xiegan Tang, documented from “Formulary of the Bureau Taiping People׳s Welfare Pharmacy (Tai Ping Hui Min He Ji Ju Fang)”. In the Yuan dynasty, medicines included Shengmai San, as reported in “Revelation of Medicine (Yi Xue Qi Yuan)”. In the Jin dynasty, the use of Chaihu Shugan San was mentioned in “Jing-Yue׳s Collected Works (Jing Yue Quan Shu)”. Finally, in the Qing dynasty, Buyang Huanwu Tang and Taohong Siwu Tang were used according to “Correction on Errors in Medical Works (Yi Lin Gai Cuo)” and “Golden Mirror of the Medical Ancestors (Yi Zong Jin Jian)”, respectively.

Nowadays in China, several new compound TCM preparations have been formulated for the treatment of cerebrovascular diseases. Based on classical formulas and approved by the State Food and Drug Administration (SFDA), these include Cerebralcare Granule^® (Yangxue Qingnao granule), Tongxinluo capsule, Shenfu injection, Danhong injection, Huatuo Zaizao extractum. The name, composition and origin of the compound TCM preparations that are derived from TCM literatures or approved by the SFDA and cited in the present review are listed in Table 1. In addition, Chinese materia medica as well as active ingredients and components included in compound TCM preparations are listed in Table 2. These represent substances of recent research interest as related to their possible roles in the pathogenesis of I/R-induced brain injury, neuron damage and the underlying mechanisms. The present review is based on 139 references published from 1995 to 2014, mainly focusing on the ameliorating effects and underlying mechanisms of TCM preparations, Chinese materia medica, and active compounds on I/R-induced cerebral microcirculatory disturbances, brain and neuron damage.

Table 1.

The name, composition and origin of compound TCM preparations.

Compound TCM preparation	Composition	Origin
Buyang Huanwu decoction	Huangqi (Radix Astragali seu Hedysari), Danggui (Radix Angelicae Sinensis), Chishao (Radix Paeoniae Rubra), Dilong (Lumbricus), Chuanxiong (Rhizoma Ligustici Chuanxiong), Honghua (Flos Carthami), Taoren (Semen Persicae)	“Correction on Errors in Medical Works” (Qing dynasty)
Chaihu Jia Longgu Muli Tang	Chaihu (Radix Bupleuri), Longgu (Os Draconis), Huangqin (Radix Scutellariae), Shengjiang (Rhizoma Zingiberis), Qiandan (Minium), Renshen (Radix Ginseng), Guizhi (Ramulus Cinnamomi), Fuling (Poria), Banxia (Rhizoma Pinelliae), Dahuang (Radix et Rhizoma Rhei), Muli (Concha Ostreae), Dazao (Fructus Jujubae)	“Treatise on Cold Damage” (Han dynasty)
Danhong injection	Danshen (Radix Salviae Miltiorrhizae), Honghua (Flos Carthami)	Approved by SFDA (Z20026866)
Dihuang Yinzi	Shengdihuang (Radix Rehmanniae Recens), Lugen (Rhizoma Phragmitis), Maidong (Radix Ophiopogonis), Renshen (Radix Ginseng), Baimi (Mel), Chenpi (Pericarpium Citri Reticulatae), Shengjiang (Rhizoma Zingiberis)	“Arcane Essentials from the Imperial Library” (Tang dynasty)
Fufang Danggui injection	Danggui (Radix Angelicae Sinensis), Chuanxiong (Rhizoma Ligustici Chuanxiong), Honghua (Flos Carthami)	Approved by SFDA (Z42021410)
Gualou Guizhi Tang	Gualou (Fructus Trichosanthis), Guizhi (Ramulus Cinnamomi), Baishao (Radix Paeoniae Alba), Gancao (Radix Glycyrrhizae), Shengjiang (Rhizoma Zingiberis), Dazao (Fructus Jujubae)	“Synopsis of the Golden Chamber” (Han dynasty)
Guizhi Fuling Wan	Guizhi (Ramulus Cinnamomi), Fuling (Poria), Gancao (Radix Glycyrrhizae), Mudanpi (Cortex Moutan Radicis), Chishao (Radix Paeoniae Rubra), Taoren (Semen Persicae)	“Synopsis of the Golden Chamber” (Han dynasty)
Huatuo Zaizao extractum	Danggui (Radix Angelicae Sinensis), Chuanxiong (Rhizoma Ligustici Chuanxiong), Bingpian (Bomeolum Syntheticum), Baishao (Radix Paeoniae Alba), Renshen (Radix Ginseng), Wuweizi (Fructus Schisandrae Chinensis), Maqianzi (Semen Strychni), Honghua (Flos Carthami), Tiannanxing (Rhizoma Arisaematis)	Approved by SFDA (Z44020748)
Huanshaodan decoction	Shudihuang (Radix Rehmanniae Preparata), Shanzhuyu (Fructus Corni), Shanyao (Rhizoma Dioscoreae), Gouqizi (Fructus Lycii), Duzhong (Cortex Eucommiae), Bajitian (Radix Morindae Officinalis), Roucongrong (Herba Cistanches), Wuweizi (Fructus Schisandrae Chinensis), Xiaohuixiang (Fructus Foeniculi), Chushizi (Fructus Broussonetiae), Niuxi (Radix Cyathulae), Fuling (Poria)	Approved by SFDA (Z50020189)
Huanglian Jiedu Tang	Huangqin (Radix Scutellariae), Huanglian (Rhizoma Coptidis), Huangbai (Cortex Phellodendri), Zhizi (Fructus Gardenia)	“Arcane Essentials from the Imperial Library” (Tang dynasty)
Naoshuantong capsule	Puhuang (Pollen Typhae), Chishao (Radix Paeoniae Rubra), Yujin (Radix Curcumae), Tianma (Rhizoma Gastrodiae), Loulu (Radix Rhapontici)	Approved by SFDA (Z20040093)
Shenfu injection	Renshen (Radix Ginseng), Fuzi (Radix Aconiti Lateralis Preparata)	Approved by SFDA (Z51020664)
Shenqi Fuzheng injection	Dangshen (Radix Codonopsis), Huangqi (Radix Astragali seu Hedysari)	Approved by SFDA (Z19990065)
Shengmai San	Renshen (Radix Ginseng), Maidong (Radix Ophiopogonis), Wuweizi (Fructus Schisandrae Chinensis)	“Revelation of Medicine” (Jin dynasty)
Taohong Siwu Tang	Shudihuang (Radix Rehmanniae Preparata), Danggui (Radix Angelicae Sinensis), Baishao (Radix Paeoniae Alba), Chuanxiong (Rhizoma Ligustici Chuanxiong), Taoren (Semen Persicae), Honghua (Flos Carthami)	“Golden Mirror of the Medical Ancestors” (Qing dynasty)
Tianma Gouteng granule	Tianma (Rhizoma Gastrodiae), Gouteng (Ramulus Uncariae cum Uncis), Shijueming (Concha Haliotidis), Zhizi (Fructus Gardeniae), Huangqin (Radix Scutellariae), Niuxi (Radix Cyathulae), Duzhong (Cortex Eucommiae),Yimucao (Herba Leonuri), Sangjisheng (Herba Taxilli), Shouwuteng (Caulis Polygoni Multiflori), Fuling (Poria)	Approved by SFDA (Z51021084)
Tongxinluo capsule	Renshen (Radix Ginseng), Shuizhi (Hirudo), Quanxie (Scorpio), Chishao (Radix Paeoniae Rubra), Chantui (Periostracum Cicadae), Tubiechong (Eupolyphaga seu Steleophaga), Wugong (Scolopendra), Tanxiang (Lignum Santali Albi), Jiangxiang (Lignum Dalbergiae Odoriferae), Ruxiang (Olibanum), Suanzaoren (Semen Ziziphi Spinosae), Bingpian (Bomeolum Syntheticum)	Approved by SFDA (Z19980015)
Xiaoxuming decoction	Mahuang (Herba Ephedrae), Guizhi (Ramulus Cinnamomi), Fangfeng (Radix Saposhnikoviae), Fangji (Radix Stephaniae Tetrandrae), Xingren (Semen Armeniacae Amarum), Huangqin (Radix Scutellariae), Renshen (Radix Ginseng), Gancao (Radix Glycyrrhizae), Dazao (Fructus Jujubae), Chuanxiong (Rhizoma Ligustici Chuanxiong), Baishao (Radix Paeoniae Alba), Fuzi (Radix Aconiti Lateralis Preparata), Shengjiang (Rhizoma Zingiberis)	“Important Prescriptions Worth a Thousand Gold for Emergency” (Tang dynasty)
Xingnaojing injection	Shexiang (Moschus), Yujin (Radix Curcumae), Bingpian (Bomeolum Syntheticum), Zhizi (Fructus Gardeniae)	Approved by SFDA (Z53021638)
Cerebralcare Granule®(Yangxue Qingnao granule)	Danggui (Radix Angelicae Sinensis), Chuanxiong (Rhizoma Ligustici Chuanxiong), Baishao (Radix Paeoniae Alba), Shudihuang (Radix Rehmanniae Preparata), Gouteng (Ramulus Uncariae cum Uncis), Jixueteng (Caulis Spatholobi), Xiakucao (Spica Prunellae), Juemingzi (Semen Cassiae), Zhenzhumu (Concha Margaritifera), Yanhusuo (Rhizoma Corydalis), Xixin (Herba Asari)	Approved by SFDA (Z10960082)

Table 2.

The structures and sources of active components of Chinese materia medica.

2. Effects of TCM preparation, Chinese materia medica, and active compounds on pathogenesis of cerebral microcirculatory disturbances induced by I/R

2.1. Oxidative stress

Significant amounts of ROS are generated during cerebral I/R, which are widely regarded as the initial step in brain damage after stroke. Numerous clinical and experimental observations have shown increased ROS formation during all forms of stroke injury. ROS are highly active and able to react with DNA, protein, and lipid directly, causing damage and dysfunction of the molecules to various degree⁴⁸. The primary source of ROS during I/R injury is the mitochondria, which produce superoxide anion radicals during the electron transport process. Other potentially important sources of ROS include xanthine oxidase, cyclooxygenase, lipooxygenase, and others, depending on cell types. Oxygen free radicals can also be generated by activated microglia and infiltrating leukocytes via the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase pathway following reperfusion⁴⁹. In recent studies, researchers found that some compound TCM preparations, Chinese materia medica and active components produce positive effects on cerebrovascular diseases partially due to their antioxidant properties. Using dihydrorhodamine 123 (DHR), a hydrogen peroxide-sensitive mitochondrial probe, researchers demonstrated in vivo that compound TCM preparations, such as Cerebralcare Granule^® attenuates DHR fluorescence intensity in gerbil cerebral microvessels, in either the early phase (60 min) or late phase (5 days) of reperfusion after global ischemia50, 51. The single active component notoginsenoside R1 was found to prevent oxidative stress by suppressing both mitochondrial and NADPH oxidase-dependent superoxide generation and inhibiting production of malondialdehyde (MDA), protein carbonyl, and 8-hydroxydeoxyguanosine (8-OHdG) in rat with middle cerebral artery occlusion (MCAO) and reperfusion in vivo³⁴. This compound also had antioxidant activity in primary cortical neurons stimulated by oxygen-glucose deprivation (OGD) followed by reoxygenation in vitro³⁴. Other compound TCM preparations, such as Yiqi Tongluo Jiedu capsule⁵², as well as several active components from Chinese materia medica (including total glycoside from Chishao, Radix Paeoniae Rubra⁵³, astragaloside13, 14, and tetrahydroxystilbene glucoside⁴⁶) alleviated ROS production in cerebral tissue via inhibiting inducible nitric oxide synthase (iNOS) activation and nitric oxide (NO) overproduction. Other experiments reported that Chinese materia medica Danshen (Radix Salviae Miltiorrhizae)⁵⁴ and active component baicalin¹⁹ exert their antioxidant effect by lowering adenosine metabolites hypoxanthine and inhibiting cyclooxygenase, respectively. In addition to ROS source regulation, TCM preparation, Chinese materia medica and active compounds ameliorate I/R-induced oxidative stress by scavenging free radicals directly or by modulating tissue anti-oxidant potency. In a recently published study, three classical formulas (Huanglian Jiedu Tang, Chaihu Jia Longgu Muli Tang, and Guizhi Fuling Wan) showed scavenging activity for free-radical superoxide anion radicals, hydroxyl radicals and 1,1-diphenyl-2-picrylhydrazyl radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl (DPPH), respectively, while suppressing lipid peroxidation⁵⁵. Another study reported that the single active component salvianolic acid A reduces the MDA contents in the cortex, hippocampus and corpus striatum in I/R rat brain, which may also attribute to its scavenging effect on free hydroxyl radicals in vitro³⁸. Shengmai San, another classical formula, improved oxidative damage manifested as suppression of MDA and thiobarbituric acid reactive substance (TBARS) formation and increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in brain tissues from rodent global or MCAO models. This treatment was active whether given before ischemia or after re-perfusion56, 57, 58. In parallel, aqueous or ethanolic extract from Baihuasuantengguo (Embelia ribes Burm) increased the glutathione (GSH), GSH-Px, glutathione reductase and glutathione-S-transferase levels in both hippocampus and frontal cortex with decreases in lactate dehydrogenase (LDH) level in serum and TBARS levels in hippocampus and frontal cortex in rat after MCAO59, 60. Lavender oil was also found to reduce the levels of mitochondria-generated ROS, MDA and carbonyl, and to upregulate the ratio of GSH/glutathione disulfide (GSSG), the activities of SOD, catalase (CAT) and GSH-Px in brain tissue after focal ischemia⁶¹. Similar antioxidant effects have been reported for some other TCM preparation, such as Tongxinluo capsule⁶², Yimucao (Herba Leonuri) injection⁶³, and active components, such as Yinxing (Folium Ginkgo) extract⁶⁴, paeonol³⁵ and 3′-methoxy-puerarin¹².

2.2. Inflammatory mediators

Inflammation is increasingly recognized to be the key element in the pathological progression of ischemic stroke, as early inflammatory responses may potentiate reperfusion injury in post-ischemic brain tissue. There are several resident cell populations within brain tissue that are able to secrete proinflammatory mediators after an ischemic insult, including endothelial cells, leukocytes, astrocytes, microglia and neurons. Activation of transcription factors via nuclear factor κ-B (NF-κB), mitogen activated protein kinase (MAPK), and activator protein-1 (AP-1) inflammatory signaling pathway causes an increased production of cytokines, chemokines, adhesion molecules and other proinflammatory mediators⁶⁵. Several agents that can regulate inflammatory mediators or transcription factors reduce infarct size and neurological deficits following focal stroke in rodents; such treatments are considered to be an alternative therapeutic approach in stroke patients⁶⁶. In this regard, Guizhi Fuling capsules, a classical formula, were reported to down-regulate the expression of pro-inflammatory cytokines [including interleukin-1β (IL-1β) and tissue necrosis factor-α (TNF-α)] and markedly up-regulate the expression of anti-inflammatory cytokines interleukin-10 (IL-10) and IL-10 receptor at both mRNA and protein levels in rats with focal cerebral I/R. The serum levels of these inflammatory cytokines were regulated in the same way⁶⁷. In other in vivo MCAO experiments, TCM Naomaitong preparation⁶⁸ and the single active component tetrandrine⁴⁷ have proven to decrease the expression and mRNA level of TNF-α, vascular adhesion molecule-1 (VCAM-1), ICAM-1 in brain tissue 1 or 3 days after reperfusion, partly due to suppressing NF-κB activation. Similar results were found for TCM preparations, such as Taohong Siwu Tang⁶⁹, FBD formula [a herbal formula composed of Fuling (Poria), Baizhu (Rhizoma Atractylodis Macrocephalae) and Danggui (Radix Angelicae Sinensis)]⁷⁰, as well as Chinese materia medica Danshen (Radix Salviae miltiorrhizae) aqueous extract⁷¹. A broad spectrum of cytokines and chemokines were abrogated by treatment with these TCM, including high-sensitivity C-reactive protein (hs-CRP), hypoxia-inducible factor (HIF)-1α, IL-1β, interleukin-8 (IL-8), TNF-α, iNOS levels in serum or brain, and TNF-α mRNA and transforming growth factor β1 (TGF-β1) expression in cerebral tissue; these effects were partly due to down-regulation of cerebral Inhibitory-κB-α (I-κBα) and NF-κB phosphrylation⁷⁰. In a global cerebral ischemia model, treatment with the single active component resveratrol before insult reduced astroglial and microglial activation as well as cyclooxygenase-2 (COX-2) and iNOS expression 7 days after I/R. These effects were attributed to suppression of NF-κB and Jun N-terminal kinase (JNK) activation³⁶. In addition to in vivo results, in vitro experiments demonstrated that another active component honokiol reduced TNF-α and NO level in the primary cultured microglia medium and in the microglia and astrocytes co-culture medium. Also, honokiol was shown to decrease the level of RANTES (regulated upon activation normal T-cell expressed and secreted) protein in medium of microglia or astrocytes, which was related to its effect on microglia NF-κB p65 nuclear translocation²⁸.

2.3. Leukocyte infiltration

A growing body of evidence indicates that recruitment of leukocytes contributes to the initiation and evolution of brain injury after ischemic stroke. The adhesion and migration of neutrophils is evident in cerebral venules from several minutes to a few hours following reperfusion. The population of recruited cells shifts from polymorphonuclear (PMN) to mononuclear leukocytes and lymphocytes, and leukocyte recruitment persists for days to weeks following ischemia72, 73. Rodents with reduced PMN or T-lymphocyte accumulation show reduced infarct volumes and improved neurological outcomes. Prevention of leukocyte–endothelial cell adhesion with adhesion molecule antibodies also protects against stroke injury⁷⁴. In a rat MCAO model, leukocyte adhesion was observed continuously in cerebral microvessels by infusion of rhodamine 6G, and the number of adherent leukocytes after I/R increased immediately and remained increased during 60 min after reperfusion. Pretreatment with TCM preparation Cerebralcare Granule^® attenuated this I/R-elicited enhancement of leukocyte adhesion; the effects of the higher dose (0.8 g/kg) were more significant than those following the lower dose (0.4 g/kg)⁷⁵. Consistently, Cerebralcare Granule^® inhibited leukocyte adhesion either during the early phase (60 min) or in the late phase (5 days) of reperfusion after global ischemia in gerbils50, 51. Using ⁵¹Cr-labeled neutrophil, researchers also demonstrated that tetrandrine decreased neutrophils recruitment in brain tissue 24 h after reperfusion in rat with MCAO⁴⁷. The classic formula Huanglian Jiedu Tang and its constituents inhibited myeloperoxidase (MPO) activity, an indication of neutrophil infiltration, in ischemic brain tissue by 30% after focal I/R⁷⁶. The same result was observed when using other TCM preparations, such as Shengmai San⁵⁶, Tongxinluo capsule⁷⁷, and Chinese materia medica Zhimu (Rhizoma Anemarrhenae)⁷⁸, either in rodent global or focal I/R injury. FBD formula inhibited PMNs infiltration in ICR mouse brain subjected to repetitive 10 min of common carotid arteries occlusion followed 24 h reperfusion, and in vitro results showed that FBD formula could inhibit TNF-α-triggered PMNs adhesion to ECV304 endothelial cells⁷⁰. In another in vitro experiment, the single active compound salvianolic acid A was proven to inhibit the adherence of granulocytes on brain microvascular endothelial cells (BMEC); the effect was attributed to decreasing the expression of ICAM-1 on BMEC at the gene and protein levels³⁹.

2.4. Brain blood barrier (BBB) disruption

BBB consists of microvascular endothelial cells, basal lamina, pericytes and astrocyte endfeet. Microvessel hyperpermeability disrupts the normal BBB function during cerebral I/R injury. Microvessel permeability is regulated by both paracellular and transcellular pathways⁷⁹. Paracellular pathways are mainly governed by tight junctions; the loss of tight junction integrity occurs and directly contributes to cerebral BBB disruption under ischemic stroke conditions⁸⁰. An alternative mechanism for BBB opening involves upregulation of caveolae, including the expression and phosphorylation of the structural component caveolin-1 (Cav-1), as demonstrated by transmission electron microscopy in endothelial cells in several stroke models⁸¹. In a rat MCAO model, recent in vivo studies found that both pre- and post-treatment with the TCM preparation Cerebralcare Granule^® reduces FITC-labeled albumin leakage from cerebral venules evoked by I/R, in either the early or late phase after reperfusion75, 82; the same results were found in a gerbil global I/R model50, 51. Further study using confocal microscopy revealed that the continuous distributions of tight junction proteins including claudin-5, occludin, junctional adhesion molecule-1 (JAM-1) and zonula occludens-1 (ZO-1) were disrupted after reperfusion for 3 h and 6 days, concomitant with reduced immune staining. Western blotting indicated the degradation of tight junction proteins in response to I/R. Interestingly, these losses in structural integrity were reversed by Cerebralcare Granule^® treatment. In addition, I/R-induced increases in the cytoplasmic caveolae of capillary endothelial cells and cerebral Cav-1 expression were both down-regulated by Cerebralcare Granule^®, as observed by electron microscopy and Western blotting, respectively. Taken together, these findings suggest involvement of both the paracellular and transcellular pathways in the beneficial effects of Cerebralcare Granule^® on BBB disruption following cerebral I/R injury⁸². Similarly, treatment with the TCM preparation Tongxinluo capsule increased ZO-1 and occludin expression in cerebral microvessels 24 h after MCAO in mice⁷⁷. In addition, enzymatic degradation of the extracellular matrix by matrix metalloproteinases (MMPs), secretion of vascular endothelial growth factor (VEGF), ROS production, leukocyte infiltration, and inflammatory mediator release within the ischemic core or peri-infarct area have all been postulated to trigger BBB disruption directly or indirectly during I/R process. To this end, TCM preparations such as naomaitong preparation⁸³, and Panax notoginseng saponins combined with astragaloside¹⁵, were reported to protect against cerebral microvessel basement membrane injury via modulating gelatinase system, inhibiting MMP-2 and MMP-9 expression and improving tissue inhibitor of metalloproteinase-1 (TIMP-1) protein level in rodent brain tissue after I/R. Using immunohistochemistry, the single active component salvianolic acid B was shown to alleviate the extravasation of immunoglobulin and attenuate MMP-9 expression induced by cerebral I/R, which was related to the inhibition on p38MAPK activation and extracellular signal-regulated kinase (ERK) 1/2 phosphorylation⁴¹. Other TCM preparations, such as Weinaokang preparation⁸⁴ and Huatuo Zaizao extractum⁸⁵, may also effectively recover BBB ultrastructure injury induced by I/R via inhibiting expressions of MMP-2 and MMP-9, which might be associated with reduction of G protein-coupled receptor kinase 2 (GRK2) in membrane translocation and activation. Another experiment showed that aromatic resuscitation drugs have the protection effect on BBB by decreasing the level of VEGF in addition to MMP-9⁸⁶. Besides, the effects of TCM preparation, Chinese materia medica and active compounds on ROS production, leukocyte infiltration and inflammation all contribute to ameliorating BBB disruption to some extent, as discussed above.

2.5. Capillary hypoperfusion

It has been known for some time that loss of microvascular patency impairs cerebral vascular re-perfusion following global or focal cerebral ischemia⁸⁷. After reperfusion, adhered leukocytes, entrapped erythrocytes, and fibrin-platelet deposits obstruct capillary lumens. Moreover, swollen astrocyte endfeet, pericyte contraction and microvessel hyperpermeability all contribute to capillary occlusion after reperfusion88, 89. A recent clinical study showed that perfusion status, rather than successful recanalization, has a significant impact on the outcome of stroke patients⁹⁰, suggesting that improvement of microcirculatory reperfusion seems to be a promising strategy in stroke patients after thrombolysis. With the use of the intravital microscopy equipped with a high-speed video camera in a rat MCAO model, researchers demonstrated that the number of open capillaries reduced considerably 60 min after reperfusion, and pre-treatment with TCM preparation Cerebralcare Granule^® attenuated this alteration⁷⁵. In addition, cerebral blood flow (CBF) in cortex decreased 3 h after I/R, and this reduction remained for 6 days. Cerebralcare Granule^® post-treatment after reperfusion attenuated the I/R-evoked decrease in CBF⁸². Consistent with the result observed by intravital microscopy and laser Doppler, transmission and scanning electron microscopy clearly identified that pre- or post-treatment with Cerebralcare Granule^® ameliorated cerebral microvasculature changes, including narrowed lumen, rough inner surface, swelling endothelial cells and perivascular astrocyte end feet. The treatment also restored the decrease in the number of open capillaries 24 h or 6 days after reperfusion75, 82. Similar results were found when using Cerebralcare Granule^® in global I/R injury⁵⁰. Assessment of hemorheology by a full-automatic hemorheolometer revealed that acupoint-injection of compound Angelica-root injection (Fufang Danggui injection) downregulated blood viscosity including high, medium and low shearing rates, erythrocyte aggregation index, and rigidity index; deformity index was up-regulated, facilitating cerebral blood circulation⁹¹. Other TCM preparations, such as Erigeron injection (Dengzhanhuasu injection)⁹², Astragalus injection (Huangqi injection)⁹³, Naosaitong preparation⁹⁴, and icariin combined with P. notoginseng saponins²⁹ were also reported to improve blood rheology and CBF after cerebral I/R injury. In addition, Gualou Guizhi decoction reduced cerebral ischemic spasticity, improved the screen test and Hoffman׳s reflex scores, which might be related to modulation of glutamate (Glu) levels and α-amino3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression⁹⁵.

3. Effects of TCM on brain injury and neuron damage induced by I/R

Within a few minutes of the onset of cerebral ischemia in stroke patients, the core of brain tissue exposed to the most dramatic blood flow reduction is mortally injured, and subsequently undergoes necrotic cell death. The reduction of oxygen and nutrient supply induces a series of metabolic dysfunctions such as reduction in ATP formation and energy failure, loss of cell ion homeostasis, acidosis, membrane depolarization, Ca²⁺ influx, excessive release of excitatory amino acids, free radical-mediated toxicity, all resulting in brain and neuron necrosis96, 97. Thrombolysis strategies have proven to be the most effective therapies for stroke treatment. However, early reperfusion of ischemic brain tissue can result in harmful consequences, including ROS outburst, overproduction of inflammatory mediators, leukocyte infiltration, microvessel hyperpermeabilty, all of which lead to BBB disruption and capillary hypoperfusion. Ultimately, activation of these cascades culminate in cerebral edema and/or brain hemorrhage and exacerbate brain injury³. On the other hand, cerebral microcirculatory disturbances, together with other neurotoxicity mediators such as Na⁺, Ca²⁺ and Glu, are detrimental to neuronal survival in the ischemic penumbra or peri-infarct zone; apoptotic neuron death is a common outcome⁹⁸.

3.1. Effects of TCM on brain injury induced by I/R

As discussed above, TCM has multiple beneficial roles in cerebral I/R-induced microcirculatory disturbances. Among these are positive effects on brain injury, such as brain infarction, peri-vascular edema and hemorrhage after I/R. In this aspect, HE staining demonstrated a histopathological damage after global or focal cerebral I/R, which could be inhibited by some TCM preparations, such as Shengmai San⁵⁶, Naomaitong preparation⁹⁹ and active component baicalin19, 20. By virtue of magnetic resonance imaging (MRI), rat brain edema was observed 3 h after MCAO and remained unchanged 6 days after reperfusion. Interestingly, TCM preparation Cerebralcare Granule^® reduced cerebral edema even when administered after the initiation of edema⁸². Likewise, scanning electron microscopy revealed swollen glia and edema around cerebral microvessels which were abrogated by Cerebralcare Granule^®50, 82 and the active component apigenin¹⁸, after global or focal I/R injury. By means of high performance liquid chromatography (HPLC) and atomic absorption spectrophotometry, the TCM preparation Shenfu injection was found to decrease glutamate and Ca²⁺ in brain tissue and reduce excitatory amino acid toxicity, effects which can alleviate tissue edema¹⁰⁰. Using Evan׳s blue dye extravasation and/or brain water content assessment, large doses of TCM preparation, Chinese materia medica, and active compounds were demonstrated to restrain BBB disruption and brain tissue edema after I/R, although the mechanisms for the effects of each TCM may differ. For example, combinations of total alkaloids from Gouteng (Ramulus Uncariae cum Uncis) and Xiatianwu (Rhizoma Corydalis Decumbentis)¹⁰¹ and the active compound sodium tanshinone B⁴⁵ were thought to act through anti-oxidation, whereas the TCM preparation Naomaitong preparation⁶⁸ and Guizhi Fuling capsules⁶⁷ may produce beneficial effects by anti-inflammatory mechanisms. In contrast, FBD formula⁷⁰ and Chinese materia medica Zhimu (Rhizoma Anemarrhenae)⁷⁸ may act through inhibition of leukocyte infiltration, whereas the TCM preparation Shexiang Xingnaoning preparation¹⁰² as suggested may act by anti-thrombotic mechanisms. Finally, Cerebralcare Granule^®82 and Tongxinluo capsule⁷⁷ are thought to maintain the BBB. Consistent with anti-edema effects, the beneficial effects of TCM preparations, Chinese materia medica and active compounds on cerebral infarction after I/R injury have also been reported. For example, 2,3,5-triphenyltetrazolium chloride (TTC) staining showed that the TCM preparation Xuezhikang capsule¹⁰³, total flavones of Chinese materia medica Huangshukui (Abelmoschus manihot)¹⁰⁴, and active compounds, such as calycosin²⁴ and astrogaloside¹⁶, inhibited brain infarction mainly by anti-oxidative effect. On the other hand, the classical formula Buyang Huanwu Tang¹⁰⁵, and TCM preparations, such as Danhong injection¹⁰⁶, Astragalus injection (Huangqi injection)⁹³, and Naosaitong preparation⁹⁴ were shown to inhibit cerebral tissue necrosis via promoting blood vessel repair¹⁰⁵, anticoagulant and antifibrinolytic activity¹⁰⁶, and improvement of capillary perfusion. In contrast studies on edema and infarction, few studies have been published showing the ameliorating effect of TCM preparations, Chinese materia medica, and active compounds on cerebral hemorrhage induced by I/R injury. However, these medicinals can alleviate intracerebral hemorrhage in some situations, such as surgery¹⁰⁷, traumatic intracranial hematoma¹⁰⁸, and artificial cerebral hemorrhage in animal models¹⁰⁹.

3.2. Effects of TCM on neuron damage induced by I/R

A variety of tests are available for evaluation of neurobehavioral function, such as Long׳s test33, 43, 93, Morris water maze test17, 19, 110, 111, 112, eight-arm radical maze test29, 113, step down and step through test40, 53, beam-walking test⁴², forced swimming test and tail suspension test¹⁰³. Using these tests, many TCM preparations, Chinese materia medica and active compounds have been shown to alleviate neurological deficits and improve learning and memory after I/R injury. These include TCM preparations such as Xiaoxuming decoction¹¹² and Yizhi capsule110, 111, and Chinese materia medica such as Sanqi (Radix et Rhizoma Notoginseng)¹¹³, and Gegen (Radix puerariae) ethanol extract¹¹⁴. The list also includes active compounds, such as astrogaloside¹⁷, salvialonic acid A⁴⁰, salvianolic acid B⁴², morroniside³³ and scutellarin⁴³. The underlying mechanism for neuroprotection in each case is distinct. Candidate mechanisms include anti-apoptosis, anti-excitoxicity and pro-neurogenesis. The following sections will discuss each of these separately.

3.2.1. Effects of TCM on apoptosis

Nissl staining and DNA fragmentation assays demonstrated that the TCM preparation Naoshuantong capsule reduced neuronal apoptosis in ischemic cortex and in the hippocampal CA1 region after rat MCAO; neurological functional deficits were also attenuated. Naoshuantong capsule also suppressed the overexpression of Bax and activation of caspases-3, -8 and -9, inhibited the reduction of Bcl-2 expression and depressed the Bax/Bcl-2 ratio¹¹⁵. Likewise, Nissl and terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining, along with electron microscopic observations, showed that the TCM preparation Cerebralcare Granule^® attenuated neuron death in cortex after focal I/R and in hippocampal CA1 region after global I/R. These beneficial effects were partly attributed to improving cerebral microcirculatory disturbances, balancing Bcl-2 superfamily protein expression, and modulation of the PUMA-p53 proapoptotic pathway51, 75. Staining with hematoxylin and eosin (HE), TUNEL and Hoechst 33258 was used to show that the classical formula Dihuang Yinzi¹¹⁶, the TCM preparation Astragalus injection (Huangqi injection)⁹³, and active compounds, such as astragalosides¹⁷ and tetrahydroxystilbene glucoside⁴⁶ attenuated neuronal apoptosis. Mechanisms for these actions include ERK activation, inhibition of JNK phosphorylation, and up-regulation of Akt phosphorylation; this last mechanism may also be important in the neuroprotective effect of eupatilin²⁵ and resveratrol³⁷. Other active compounds, such as Leonurine³⁰ and ginsenoside Re²⁶ were reported to attenuate I/R-induced mitochondrial swelling, reverse changes in mitochondrial membrane potential, and restore cytochrome c levels in mitochondria. The anti-apoptotic actions of these preparations were suggested to contribute to these effects. Another experiment found that the active compound scutellarin alleviated mitochondrial dysfunction through inhibition of poly-ADP-ribose polymerase (PARP) overactivation and the subsequent translocation of apoptosis inducing factor (AIF) from mitochondria to nuclei following cerebral I/R⁴³. Other TCM preparations, such as Buyang Huanwu decoction¹¹⁷, Xingnaojing plus Xuesaitong injection¹¹⁸, Naoshuantong capsule¹¹⁹, Yinxing (Folium Ginkgo) extract¹²⁰, and active compounds, such as ginsenoside Rg3²⁷ and lycopene³² displayed similar neuroprotective actions via anti-apoptotic effects.

3.2.2. Effects of TCM on excitoxicity

Excitatory amino acids accumulate in the extracellular space following ischemia and activate their receptors, leading to intracellular Ca²⁺ overload followed by neuronal damage. HPLC results demonstrated that the classical formula Buyang Huanwu decoction¹²¹, Tianma Gouteng Fang¹²², and Chinese materia medica Yinxing (Folium Ginkgo) extract¹²³ decreased brain levels of the excitatory amino acids Glu and aspartate (Asp), and increased levels of the inhibitory amino acids γ-aminobutyric acid (GABA), taurine and glycine (Gly). Such a pattern seems to maintain the balance of inhibitory and excitatory amino acids in brain after I/R injury. TCM preparations, Chinese materia medica and active compounds have also been reported to influence the excitatory amino acid receptors. For example, TCM preparations such as Huanshaodan decoction¹²⁴ and Tianma Cuzhi granules¹²⁵ were found to reduce the N-methyl-d-aspartic acid (NMDA) receptor activity in both cerebral cortex and hippocampus. Single active components, such as sodium tanshione B⁴⁵ and senegenin⁴⁴ decreased NMDA receptor protein expression and mRNA levels of its NR2B subunit in hippocampus. The classical formula Buyang Huanwu decoction¹²⁶ decreased neurological deficit scores via down-regulating AMPA receptors, glutamate receptor-1 RNA and glutamate receptor-2 protein expression. In primary hippocampal neuron cultures, an active component flavonoid extract from Shishu (Diospyros kaki) leaves¹²⁷ and Yinxing (Folium Ginkgo) extract¹²⁸ protected neurons from Glu- or NMDA receptor-induced excitotoxicity. Also, microfluorometry showed that the Chinese materia medica Yinxing (Folium Ginkgo) extract decreased intracellular Ca²⁺ concentrations in primary cultured hippocampal neurons treated with Glu¹²³. In addition, injections of the TCM preparation Shenqi Fuzheng improved neuronal deficits, an effect which was suggested to be related to inhibition of Ca²⁺ aggregation in brain¹²⁹.

3.2.3. Effects of TCM on neurogenesis

Given that the proliferation of endogenous neuron stem cells and neurogenesis occurs in rodents¹³⁰, as well as in primate¹³¹ and patients¹³² after ischemic stroke, pharmacological interventions related to neurogenesis are believed to be a key strategy to improve the neuron functions after cerebral I/R injury. TCM finds its role in this field as well. It was reported that the TCM preparation Tongxinluo capsule increased the number of nestin-positive neurons and VEGF mRNA expression in the rat subventricular zone and hippocampal subdentate gyrus zone of the ischemic hemisphere after MCAO, indicating a capacity of promoting differentiation and proliferation of the neural stem cells133, 134. In addition to VEGF, brain-derived neurotrophic factor (BNDF)21, 22, 113, basic fibroblast growth factor (bFGF)¹³⁵ and nerve growth factor (NGF)¹³ may also be targets for the pro-neurogenic potential of some TCM preparations (e.g., Naoluo Xintong recipe¹³⁵), Chinese materia medica (e.g., Sanqi (Radix et Rhizoma Notoginseng)¹¹³), and active components (baicalin21, 22 and astragaloside¹³). In an in vitro study, P. notoginseng saponins, active components extract from Sanqi (Radix et Rhizoma Notoginseng), was shown to promote rat hippocampal neural stem cells (NSC) proliferation and the expression of nestin/BrdU. mRNA levels of class III β-tublin (Tuj-1), vimentin, and nestin were also enhanced. Also, P. notoginseng saponins increased area density, optical density and numbers of nestin/BrdU, nestin/vimentin, and nestin/Tuj-1 positive NSC following OGD¹³⁶. The TCM preparation Weinaokang preparation¹³⁷ and the single active component salvianolic acid B⁴², among others, were reported to improve neurogenesis and to promote the repair of ischemic areas.

3.2.4. Other neuroprotective mechanisms of TCM preparation, Chinese materia medica and active compounds

In addition to aforementioned mechanisms, TCM preparations, Chinese materia medica and active compounds are known to alleviate neuron damage after cerebral I/R indirectly via anti-oxidant, anti-inflammatory roles and promotion of capillary perfusion around neurons. For example, the classical formula oren-gedoku-to (Huanglian Jiedu Tang) lowered neuronal death by increasing the expression of Cu/Zn-SOD in the hippocampus of ischemic mice¹³⁸. The TCM preparation Breviscapine injection (Dengzhanhuasu injection)¹³⁹, and active compounds, such as total glycoside from Chishao (Radix Paeoniae Rubra)⁵³ and luteolin³¹, ameliorated neurological deficit and improved neuronal function through anti-oxidant actions as well. In addition, electron microscopic studies found that TCM preparations, such as Cerebralcare Granule^®51, 75, Shexiang Xingnaonin preparation¹⁰² and the single active compound apigenin¹⁸, exhibited a potential to decrease neurological scores and improve pathomorphology and neuron ultrastructure of ischemic cortex and hippocampal CA1 region after I/R. Suggested mechanisms for these effects include inhibition of cytokine production and platelet aggregation¹⁰², or promotion of capillary opening51, 75. Similarly, HE staining was used to show that the active compound baicalin increased neurons with pycnotic shape and condensed nuclei in cortex and hippocampus, effects which were related to suppression of NF-κB p65 activation²³.

4. Summary

The present paper provides an overview of the ameliorating effects of compound TCM preparations, Chinese materia medica and active components on I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage, as summarized in Fig. 1.

• (1)Many studies demonstrated that compound TCM preparations, Chinese materia medica and their active components can ameliorate I/R-induced cerebral microcirculatory disturbances, including enhanced ROS production, release of cytokines/chemokines/adhesion molecules, leukocyte recruitment, microvessel hyperpermeability, BBB disruption and capillary hypoperfusion (Table 3).
• (2)Compound TCM preparations, Chinese materia medica and their active components are capable of ameliorating I/R-induced brain injury, such as brain infarction and perivascular edema. Such effects are attributable to beneficial actions on cerebral microcirculatory disturbances, together with attenuation of excitoxicity (Table 4).
• (3)Compound TCM preparations, Chinese materia medica and their active components have the potential to alleviate neurological deficits and improve learning and memory capacity after I/R injury. Underlying mechanisms for these effects include inhibition of apoptosis, excitoxicity, oxidation and inflammation, along with stimulation of pro-neurogenesis (Table 5).
• (4)In spite of a number of clinical studies illustrating the ameliorating effects of TCM preparations, Chinese materia medica and active compounds on cerebral I/R-related diseases, strictly randomized, double-blind, placebo-controlled, and multicenter clinical trials remain to be conducted with large samples. More evidence-based data are required to confirm the effects of TCM preparation, Chinese materia medica and active compounds, especially Chinese classic formulas, on ischemic stroke in clinical studies.
• (5)Majority of the studies concerning the protective effects of TCM preparation, Chinese materia medica and active compounds on I/R-induced cerebral injury and neuron damage focus on ROS production, cytokine release, leukocyte recruitment and microvessel hyperpermeability. More attention should be paid to other microcirculatory insults, including platelet aggregation, mast cell degranulation, thrombus formation and lymphocyte activation. Furthermore, future studies should place more emphasis on mechanistic exploration in depth rather than merely descriptive observation. For instance, what is the relationship between brain injury (especially cerebral microcirculatory disturbances) and delayed neuron damage? What are the initiating effector/receptor and specific signaling molecules for TCM preparations, Chinese materia medica and active compounds to regulate inflammatory responses, such as ROS production, cytokine release and leukocyte activation? Moreover, additional mechanisms that participate in ischemic brain injury and neuron damage should be addressed further in studying the role of TCM preparation, Chinese materia medica and active compounds in cerebral I/R injury. These energize metabolism, microglia activation, aquaporin molecules, and cyclic adenosine monophosphate (cAMP).

Figure 1.

Schematic summary of how the TCM preparation, Chinese materia medica and active compounds ameliorate I/R-induced cerebral microcirculatory disturbances, brain injury and neuron damage. TCM preparation, Chinese materia medica and active compounds inhibit I/R-induced multiple insults in cerebral microcirculation, including ROS outburst, inflammatory mediators overproduction, leukocyte infiltration, microvessel hyperpermeabilty, platelet aggregation, etc., leading to BBB disruption and capillary hypoperfusion, which culminate in ameliorating cerebral edema and/or brain hemorrhage, and brain injury. On the other hand, by improving cerebral microcirculation, together with anti-apoptosis, anti-excitoxicity and pro-neurogenesis effects, TCM preparation, Chinese materia medica and active compounds have potential to alleviate neurological deficits after I/R. BBB, blood brain barrier; EC, endothelial cell; H₂O₂, hydrogen peroxide; I/R, ischemia/reperfusion; MMPs, matrix metalloproteinases; NADPH, nicotinamide adenine dinucleotide phosphate; O₂⁻, superoxide anion; OH⁻, hydroxyl radicals; ONOO⁻, peroxynitrite anion; ROS, reactive oxygen species, TCM, traditional Chinese medicine; XO, xanthine oxidase; ⊥ denotes inhibition.

Table 3.

Effect of TCM preparation, Chinese materia medica and active compounds on pathogenesis of cerebral microcirculatory disturbances induced by I/R.

Effect	Target	TCM	Refs.
Amelioration of oxidative stress	ROS source	Cerebralcare Granule®	50, 51
Yiqi Tongluo Jiedu capsule	52
Chishao total glycoside	53
Danshen	54
Astragaloside	13, 14
Baicalin	19
Notoginsenoside R1	34
Tetrahydroxystilbene glucoside	46
Free-radical scavenger	Chaihu Jia Longgu Muli Tang	55
Guizhi Fuling Wan	55
Huanglian Jiedu Tang	55
Salvianolic acid A	38
Anti-oxidase activity	Shengmai San	56, 57, 58
Tongxinluo capsule	62
Baihuasuantenggou extract	59, 60
Lavender oil	61
Yimucao injection	63
Yinxing extract	64
3′-Methoxy-puerarin	12
Paeonol	35
Amelioration of inflammation	Cytokines/chemokines	FBD formula	71
Guizhi Fuling capsule	67
Naomaitong preparation	68
Taohong Siwu Tang	69
Danshen	71
Honokiol	28
Tetrandrine	47
Adhesion molecules	Naomaitong preparation	68
Tetrandrine	47
Other mediators (TGF-β1, iNOS, Cox-2)	Taohong Siwu Tang	69
Danshen	71
Honokiol	28
Resveratrol	36
Amelioration of leukocyte infiltration	Leukocyte-endothelial interaction	Cerebralcare Granule®	50, 51, 75
FBD formula	70
Salvianolic acid A	39
Tetrandrine	47
MPO increase	Huanglian Jiedu Tang	76
Shengmai San	56
Tongxinluo capsule	77
Zhimu	78
Amelioration of BBB disruption	Endothelial cell junction	Tongxinluo capsule	77
Cerebralcare Granule®	82
MMP/TIMP balance	Huatuo Zaizao extractum	85
Naomaitong preparation	83
Weinaokang preparation	84
Aromatic resuscitation drugs	86
Panax notoginseng saponins plus astragaloside	15
Salvianolic acid B	41
Amelioration of capillary hypoperfusion	CBF	Naosaitong preparation	94
Cerebralcare Granule®	50, 75, 82
Astragalus injection	93
Erigeron injection	92
Hemorheology	Compond Angelica-root injection	91
Icariin plus Panax notoginseng saponins	29
Cerebral spasticity	Gualou Guizhi decoctiom	95

Table 4.

Effect of TCM preparation, Chinese materia medica and active compounds on brain injury induced by I/R.

Effect	Mechanism	TCM	Refs.
Amelioration of brain edema	Inhibiting excitoxicity	Shenfu injection	100
Anti-oxidation	Shengmai San	56
Cerebralcare Granule®	50
Gouteng total alkaloids	101
Xiatianwu total alkaloids	101
Sodium tanshinone B	45
Anti-inflammation	Guizhi Fuling capsules	67
Naomaitong preparation	68
Shengmai San	56
Baicalin	20
Inhibiting leukocyte infiltration	FBD formula	70
Cerebralcare Granule®	50, 75
Zhimu	78
Anti-thrombosis	Shexiang Xingnaoning preparation	102
Maintaining BBB	Tongxinluo capsule	77
Cerebralcare Granule®	82
Amelioration of brain infarction	Anti-oxidation	Xuezhikang capsule	103
Huangshukui total flavones	104
Astragaloside	16
Calycosin	24
Anti-thrombosis	Danhong injection	106
Improve capillary perfusion	Naosaitong preparation	94
Astragalus injection	93
Promote blood vessel repair	Buyang Huanwu Tang	105

Table 5.

Effect of TCM preparation, Chinese materia medica and active compounds on neuron damage induced by I/R.

Effect	Mechanism	TCM	Refs.
Anti-neuronal apoptosis	Down-regulating caspases	Buyang Huanwu Tang	117
Ginsenoside Rg3	27
Morroniside	33
To balance Bcl-2/Bax	Naoshuantong capsule	115
Xiaoxuming decoction	112
Cerebralcare Granule®	51
Lycopene	32
Restoring mitochondrial membrane potential	Leonurine	30
Ginsenoside Re	26
Regulating p53-PUMA pathway	Cerebralcare Granule®	75
Regulating MAPK/Akt pathway	Dihuang Yinzi	116
Astragalus injection	93
Astragaloside	17
Eupatilin	25
Resveratrol	37
Tetrahydroxystilbene glucoside	46
Regulating PARP-AIF pathway	Scutellarin	43
Anti-neurotoxicity	Decreasing excitoxicity amino acids	Buyang Huanwu Tang	121
Tianma Gouteng Fang	122
Gegen ethonal extract	114
Yinxing extract	120, 123
Decreasing excitoxicity amino acid receptor	Buyang Huanwu Tang	126
Huanshaodan decoction	124
Tianma Cuozhi granules	125
Shishu leaves flavonoids extract	127
Yinxing extract	128
Senegenin	44
Sodium tanshinone B	45
Decreasing [Ca2+]i	Shenqi Fuzheng injection	129
Yinxing extract	123
Neurogenesis	Promoting NSC proliferation	Tongxinluo capsule	133, 134
Panax notoginseng saponins	136
Increasing neurotrophic factors (VEGF, BNDF, bFGF, NGF)	Naoluo Xintong recipe	135
Sanqi	113
Astragaloside	13
Baicalin	21, 22
Promoting neuronal self-repair	Weinaokang preparation	137
Salvianolic acid B	42
Amelioration of microcirculatory disturbances	Anti-oxidation	Huanglian Jiedu Tang	138
Xingnaojing plus Xuesaitong injection	118
Breviscapine injection	139
Chishao total glycoside	80
Yinxing extract	120
Icariin plus Panax notoginseng saponins	29
Luteolin	31
Lycopene	32
Salvianolic acid A	40
Anti-inflammation	Shexiang Xingnaonin preparation	102
Yinxing extract	120
Apigenin	18
Baicalin	19, 23
Lycopene	32
Promoting capillary perfusion	Cerebralcare Granule®	51, 75

Ischemic stroke, post I/R-induced cerebral microcirculatory disturbances, subsequent brain injury, and neuron damage are complicated processes, and require interventions at multiple targets for successful treatment. TCM preparations and Chinese materia medica contain multiple active ingredients which been widely used for decades in the clinic as a potential therapeutic strategy for I/R-related cerebral diseases. Further clinical and experimental research is needed to understand their actions.